Aadi Bioscience Inc. (AADI)
2.31
-0.25 (-9.77%)
At close: Mar 03, 2025, 3:59 PM
2.41
4.56%
After-hours: Mar 03, 2025, 07:17 PM EST
Aadi Bioscience Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Net Income | -65.77M | -60.51M | -110.09M | -3.48M | -23.27M | -10.4M | -21.4M | -16.98M | -17.07M | -28.7K | -27.36K | -27.18K | -22.39K | -22.39K | -20K | n/a |
| Depreciation & Amortization | 169K | 159K | 105K | 9K | 76.5K | 46.69K | 51.27K | 69.67K | 57.98K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Stock-Based Compensation | 11.95M | 9.64M | 2.11M | 139K | 106.14K | 3.43M | 649.41K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | 3.62M | -1.32M | -10.19M | 2.28M | 325.09K | -754.71K | -68.73K | 515.86K | -1.34M | -26.8K | -30.07K | -28.18K | -1.89K | -3.78K | -505 | n/a |
| Other Non-Cash Items | -2.62M | 2.89M | 836K | 982K | 3.6M | 1.66M | -572.2K | 819.18K | 585.8K | 33.68K | 34.05K | 31.78K | 69.44K | -625 | -1.88K | n/a |
| Deferred Income Tax | n/a | n/a | 72.38M | 153K | -2.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -3.4M | -1.82M | 12.24M | -10.51M | -1.89M | 1.11M | 1.54M | 515.86K | -1.34M | -28.3K | -31.2K | -27.36K | -66.29K | 3.78K | 505.00 | n/a |
| Operating Cash Flow | -59.66M | -49.64M | -22.42M | -12.7M | -23.85M | -5.81M | -18.88M | -15.72M | -17.88M | -23.32K | -24.52K | -22.77K | -19.24K | -19.24K | -21.37K | -31.77K |
| Capital Expenditures | -3.97M | -444K | -46K | n/a | -236.95K | -37.91K | -8.9K | -113.3K | -41.04K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | 132.44M | 25.2M | n/a | n/a | n/a | 50K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -64.44M | -145.19M | n/a | n/a | n/a | n/a | -41.1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 151.62M | 12.75M | n/a | n/a | n/a | n/a | 50K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -132.44M | -4.5M | -19.02K | -236.95K | -37.91K | -50K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | 83.21M | -132.89M | 25.15M | -19.02K | -236.95K | -37.91K | 41.1K | -113.3K | -41.04K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | 1.19M | 8.07M | n/a | 297.35K | 12.54M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.26K | -6.28K | -4.61K | -4.13K | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | -4.41M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 326K | 120K | -8.78M | n/a | n/a | -3.5M | -3.08M | -264.25K | 32K | 25K | 25K | 25K | 35K | 35K | 25K | n/a |
| Financial Cash Flow | 326K | 72.62M | 141.8M | 1.19M | 8.07M | 48.2M | 37.5M | 12.3M | 3K | 25K | 25K | 25K | 35K | 35K | 25K | n/a |
| Net Cash Flow | 23.87M | -109.91M | 144.53M | -11.51M | -24.09M | 42.35M | 18.65M | 1.59M | 5.14M | 1.68K | 482.00 | -22.77K | 15.76K | 15.76K | 3.63K | -31.77K |
| Free Cash Flow | -63.63M | -50.08M | -22.47M | -12.7M | -24.09M | -5.85M | -18.89M | -15.83M | -17.93M | -23.32K | -24.52K | -22.77K | -19.24K | -19.24K | -21.37K | -31.77K |